Cogent Biosciences, Inc.COGTNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank30
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-7.30
↓ 32% vs avg
Percentile
P30
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-5.52
Historical baseline
PeriodValueYoY Change
2025-7.30-130.6%
2024-3.17-30.1%
2023-2.43+49.7%
2022-4.84-5.3%
2021-4.60-176.4%
2020-1.66-129.5%
2019-0.72+77.1%
2018-3.17+75.4%
2017-12.89+10.2%
2016-14.36-